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‘At a time when Anaesthesia & Surgery has become safer and more effective than ever 
before, it is ironic that considerable number of  patients  remain fearful ’.
“Patients may be afraid of not waking up again, not being put into sleep adequately, and 
the fear of unknown”.
“The shift towards day care surgery has impeded the effective necessary premedications. 
As a consequence patient arrives at a day care facility in a markedly anxious state”.
“Anaesthesiologists fail to recognize the fact that emotional stress often causes greater 
suffering than complications like nausea, vomiting and headache. A child who cries for weeks 
after leaving the hospital and who will not leave his mother’s side is certainly suffering from an 
enviably severe insult.
- ROBERT.M.SMITH”
“Unpremedicated  and  anxious  patients  require  larger  doses  of  induction  agents  if 
awareness during instrumentation of airway has to  be avoided”.
“Premedication is the JOB  of an anesthesiologist”.
“The selection of drugs is important  as it  is  said that anaesthesia begins when these 
drugs are given”.
“The wise choice of medication can pave the way for an uncomplicated anaesthesia and 
post operative course where as an improper choice can lead to unsatisfactory experience to all 
concerned.”  
Claude Bernard observed that use of morphine before chloroform in a dog resulted in 
achieving anaesthesia in a smooth, rapid manner and with lesser dosage of chloroform. Ever 
since the realization of the importance of giving drugs before the induction of anaesthesia, the 
search for an ideal premedicant  has been going on.  
“ANAESTHESIA IS A SCIENCE BUT IT IS PRACTISED AS AN ART’.
AIM OF THE STUDY
   To compare the efficacy of Two doses of ketamine with Midazolam and ketamine 
alone and midazolam alone as oral premedication in children. The quality of premedication was 
assessed by using parameters  such as the level  of  sedation prior  to induction,  the  level  of 
anxiety  at  the  time  of  separation  from  parents,  anxiety  levels  at  the  time  of  intravenous 
cannulation and at the time of mask ventilation.
PREMEDICATION
I like to give a teaspoonful of brandy , without water, a few minutes before hand, but not 
so much as a tablespoonful . If wine be given or if the patient must have some water in the 
brandy then they should be given half an hour before inhaling, to allow time for absorption 
-  Clover JT , 1874 
In the Pre-anaesthetic days, both wine and opium were given to mitigate the terrors of 
surgery. The word Premedication first appeared in print in an article by the American editor – 
anaesthetist  Frank Hoeffer McMechan {1873 – 1930} in 1920.
Premedication can be defined as prescribing one or more drugs appropriately chosen  in 
appropriate  doses and  administering  it by  the appropriate route in the right time before 
induction of anaesthesia,   so as   to have a beneficial effect  on the systems of the  patient 
preoperatively, intraoperatively,  and post operatively.
THE OBJECTIVES OF PREMEDICATION ARE:
1. To produce sedation, allay anxiety and fear, reduce emotional upset [ fear of unknown, 
fear of  death, fear of not becoming conscious again].
2. To provide amnesia for the perioperative period while maintaining cooperation prior to 
loss of consciousness.
3. To relieve the pre-operative pain, if present.
4. To block the unwanted autonomic reflexes induced either by surgical manipulations or 
anaesthetic procedures.
5. To prevent excessive secretions in the airway.
6. To reduce the acidity and volume of gastric contents.
7. To decrease post-operative nausea and vomiting.
8. To  reduce  the  stress  response  during  perioperative  period  and  facilitate  induction  of 
anaesthesia.
9. To supplement anaesthesia and reduce the dose of drugs used in general anaesthesia.
6 A’ S  -  ANXIOLYSIS , AMNESIA, ANTIAUTONOMIC,
ANTACID, ANTIEMETIC, & ANALGESIC.
THE IDEAL PREMEDICATION :
       - should be easily administered.
  - should be well accepted by the patients.
 - should not prolong emergence from anaesthesia.
 - must act rapidly.
 - must have few side effects.











1. Most commonly employed route for drug administration.
2. Easiest route.
3. More convenient for administration.
4. Economical.
5. Very safe. 
6. Does not need assistance.
7. Non-invasive, often painless.
8. Need not be sterile.
DISADVANTAGES
1. Onset of action of the drug is slow and thus not suitable for emergencies.
2. Unpalatable  drugs  are  difficult  to  administer;  drug   may  be  filled  in  capsules  to 
circumvent this
3. May cause nausea and vomiting.
4. Reduced absorption of some drugs because of their physical characteristics.
5. Irregularity in absorption in the presence of food or other drugs.
6. Some drugs are destroyed by digestive juices.
7. Some drugs have increased hepatic first pass metabolism and reach blood in minimal 
concentrations
8. Irritation to the gastro-intestinal mucosa may cause emesis.
9. This route cannot be employed in  unco-operative children and  unconscious or  a 
vomiting patient.
Oral ingestion is the oldest and commonest mode of drug administration. Both solid and 
liquid dosage forms can be given orally.
THREE  PEOPLE AND THREE CONSIDERATIONS
Patient          →  Physical status, Physiological and 
                           Psychological conditions.
Surgeon        →  Requirements, Type of Surgery and 
                       Duration.
Anaesthetist   → Technique, Skill and Knowledge.
PREMEDICATION  IN CHILDREN
In 1938, Water published a monograph on premedication, in which he advised three 
types of approaches which holds good even today. He recommended
1. – Basal anaesthesia
2. -  Sedation without depression
3. -  No Medication.
Anxiety levels of children can be classified into different grades and premedication can 
be planned accordingly.
Enormous [time of] stress for the child occurs during their seperation from parents, in 
strange surroundings and during painful, frightening procedures. Children’s anxiety also focus 
on issues such as fear of needles, a concern of change in bodily image, or not awakening at the 
end of surgery or of survival.26
“I am allergic to needles-----” says a young patient
The entire family will  undergo the psychological  stress26 of a child’s   surgery;  with 
feelings of guilt, helplessness and inconvenience. Parental anxiety will be transmitted to young 
children.
The paediatric anaesthesiologist not only has to take care of the [safety of ] child but 
also has to manage the parents.26
Premedication not only takes care of the child’s anxiety, it provides emotional support 
and psychological preparation.
Parental anxiety is reduced if the child is calm and sedated, and decreases the desire of 
the parents to remain with the child during induction. Many studies12 have proved that pre-
operative sedation is superior to parental presence for decreasing anxiety during induction of 
anaesthesia and increasing the cooperation with inhalational induction.
Children sedated before coming to the operating room may have fewer stress related 
behavioural changes in the immediate postoperative period compared with groups of patients 
who received no sedation.
Thus Premedication helps to avoid a turbulent and stormy induction.
During the administration of Premedication the following factors have to be considered:-
1. Children  fear  needles  and  intensely  dislike  injections.  Moreover,  intramuscular 
injections are painful and is not a good way to induce tranquility.
2. The beneficial effect of Premedicant drug should not be negated by the side effect that 
increases the discomfort.
3. Children do remember past experiences and know what they like and do not like.  All 
one has to do is to spend enough time to ask them. Pre-anaesthetic  premedication need 
to be individualised to the patient.
4. Timing of premedication is essential. Administering a fast acting agent for a procedure 
that will not take place for hours makes little sense. Conversely, administering a slow 
acting drug for a procedure that will begin immediately offers  no benefit to the child.
Newer drugs offer some new horizons in paediatric premedications.19
PHARMACOLOGY OF MIDAZOLAM
HISTORY 
→ Fryer & Walser in 1976 synthesized Midazolam as the  first clinically used    water 
soluble benzodiazepine.
→First Benzodiazepine  that  was produced primarily for use in anaesthesia.
STRUCTURE  
8 – chloro – 6 [2– fluoro phenyl ] 1- methyl-
4H – imidazol [ 1, 5a ] [ 1,4 ] benzodiazepine
Midazolam solution contains 1 or 5 mg/ml of midazolam with 0.8% sodium chloride 
and 1% benzyl  alcohol   as  preservative.  Preservative  free  midazolam [5  mg /  ml]  is  also 
available.
The  imidazole  ring  in  its  structure  accounts  for  its  stability  in  solution  and  rapid 
metabolism.  The  parenteral  solution  of  midazolam  is  water  soluble  and  formulated  in  a 
buffered acidic medium with a  PH of   3.5 .
Midazolam is characterised by a PH  dependent ring opening phenomenon, ring remains 
open at PH <  4 thus maintaining  water solubility; ring closes at PH > 4 making it highly lipid 
soluble.20
The molecular weight of  midazolam  is 362 and has a PK of 6.15.
 METABOLISM
Midazolam  undergoes  extensive  hydroxylation  by  hepatic  microsomal   oxidative 
mechanisms  [  cytochrome  P450  3A  ]  to  form  1  –  hydroxymidazolam  and   4- 
hydroxymidazolam. These metabolites have pharmacologic activity but are less potent than 
midazolam.21 They are conjugated with glucuronic acid and excreted in urine more rapidly than 
midazolam.  With  normal  hepatic  and  renal  function  these  metabolites  do  not  prolong  the 
activity.
PHARMACOKINETICS
Midazolam  is  extensively  bound  to  plasma  proteins,  96-98%.   Despite  its  prompt 
passage into brain, it has a slow effect-site  equilibration time of  0.9 to 5.6 mints.20
Its volume of distribution is 1.1 – 1.7 L / kg and has a elimination  half time of  1.7 – 2.6 
hrs  with  a  clearance of  6.4 – 11 ml / kg /minute.  Plasma levels required for hypnosis and 
amnesia during surgery are                  100 – 200  ng / ml,  with awakening occurring at levels 
lower than 50 ng / ml.
The short duration of action is due to its rapid redistribution and rapid hepatic clearance. 
The elimination  half life is prolonged in elderly patients  and morbid obesity.
Midazolam is rapidly  absorbed from the gastrointestinal tract but only  about 50% of 
the dose reaches the systemic circulation, reflecting a substantial first-pass hepatic effect. Peak 
plasma concentration is achieved in 1 hr.  Bioavailability is between 40 –50 %.
MECHANISM OF ACTION 
Midazolam binds with the benzodiazepine receptor on gamma–2 subunit of GABA–A 
receptor [gamma amino butyric acid] with an  affinity 3 – 6 times greater than diazepam. With 
activation,  gating  of  the  channel  for  chloride  ions  is  triggered.  The  cell  becomes 
hyperpolarized and therefore resistant to neuronal excitation.
Various effects of benzodiazepines is  related to  amount of receptor occupancy which 
corresponds to plasma concentration :21
Receptor occupancy of  20 % causes Anxiolysis.
           Receptor occupancy of  30 – 50 % causes Sedation
          Receptor  occupancy of  > 60 % causes Unconsciousness.
PHARMACOLOGIC ACTION
     ONSET   I V    :  30 – 60 seconds.   
                     Oral    : 15 – 30  minutes.
DURATION   I V  :  30 – 60  minutes.
                       ORAL : 45 – 90 minutes.
EFFECTS ON ORGAN SYSTEMS
CENTRAL NERVOUS SYSTEM :
Midazolam produces sedation, hypnosis, anxiolysis, amnesia, and unconsciousness. It 
has  an  anticonvulsant  effect  and  centrally  produced muscle  relaxation  property.  In  a  dose 
related manner it causes reduction in cerebral metabolic rate of oxygen consumption [CMRO2] 
and cerebral blood flow [CBF]. It increases the seizure initiation threshold to local anaesthetics. 
Its  cerebral  protective  effect  against  hypoxia  is  superior  to  diazepam  but  inferior  to 
barbiturates.  
RESPIRATORY SYSTEM :
Midazolam causes dose related ventilatory depression (greater than diazepam & other 
benzodiazepines). Depression of respiration is more marked following a rapid administration 
by intravenous route and is insignificant when given through oral route.21
It occurs rapidly with in 3 minutes & lasts longer for even 60 –120 minutes. Patients 
with chronic obstructive pulmonary disease experience greater midazolam induced respiratory 
depression.
The slope of ventilatory response curve to carbon-di-oxide is flatter than normal.21
Midazolam induction produces apnoea which is greater in old age, debilitated state & in 
the presence of opioids or other respiratory depressant drugs.
CARDIOVASCULAR SYSTEM :
Midazolam  by  decreasing  the  systemic  vascular  resistance,  decreases  the  arterial 
pressure greater than other benzodiazepines but similar to thiopentone.
The plateau plasma level  for midazolam is 100 ng / ml above which there  is  little 
change in arterial blood pressure. Heart rate, ventricular filling pressure and cardiac output are 
maintained  after  induction.  Midazolam  impairs  baroreceptor  reflex  and  also  can  decrease 
catecholamines.  Thus, in combination with opioids midazolam can produce greater decrease in 
systemic blood pressure. 21
FOETUS :
Less placental  transfer than other benzodiazepines
Greater  Neonatal depression than thiopentone and propofol.
DRUG INTERACTIONS
1. Erythromycin and calcium channel  blockers  inhibit  cytochrome P450 3A,  hence 
decrease the hepatic clearance of midazolam resulting in unexpected central nervous 
system depression.
2. Hepatic  clearance   of  midazolam  is  inhibited  by  fentanyl  [  cyto  P450  3A  – 
metabolizes fentanyl] 
3. Antifungal  agents  like  itraconazole  and  ketoconazole  increase  the  serum 
concentrations of midazolam. 
4. Inhibition  of  oxidative  enzyme  function  by  cimetidine  impairs  the  clearance  of 
midazolam.
5. Habitual alcohol consumption, increases the clearance of midazolam.
6. Ethanol,  barbiturates,  opioids  and  other  central  nervous  system  depressants 
potentiates its effects.
7. It  reduces the minimum alveolar concentration  of  volatile agents as much as 30%.
ROUTES OF ADMINISTRATION 
Intravenous   route  commonly  used.  Other  methods  available  are  oral  route  for 
premedication. Intramuscular route for sedation and premedication. Intranasal and rectal routes 
for premedication  in children.
DOSAGE
Oral :   0.5 - 0.75 mg/ kg.
Rectal :   0.25 - 0.5  mg/kg.
  Intra nasal :   0.2 - 0.5  mg/kg.
Intramuscular:   0.05 – 0.15 mg/kg.
Intra venous :   0.05 – 0.15 mg /kg.
CLINICAL USE
1. Premedication:
Midazolam  is  an  useful  premedicant  because  of  various  available  routes  of 
administration.  It  provides  reliable  sedation,  anxiolysis   and  amnesia  in  children  without 
producing a delayed awakening.25
  Oral formulation of Midazolam was approved by US Food & Drug administration in 
1998, as a useful premedicant in children. Parenteral preparation can be administered orally but 
the problem of its bitter taste is negated by adding sugar solution.
Intramuscular  route  can  also  be  used  for  premedication  in  adults.  Transmucosal 
[sublingual]  and intranasal midazolam are other novel routes for premedication in children.
2. IV sedation:
Midazolam 1 – 2.5 mg IV  is effective for sedation during regional anaesthesia as well 
as for brief procedures. It is also useful in  procedures like cardioversion and electroconvulsive 
therapy. It plays a major role in neuroimaging and radiological interventional procedures.
Synergistic effects with opioids permits a decrease in midazolam dose
administered.
Midazolam scores over other benzodiazepines for the reasons : it is water soluble, no 
venous  irritation, rapid onset, short duration, greater amnesia and less postoperative sedation.
At 4 mcg / kg / minute, it can be used as a continuous infusion or as  patient controlled 
administration.
3. Induction of Anaesthesia :
Benzodiazepine of choice for induction. Usual induction dose between  0.05 and 0.3 mg/
kg over 30 – 60 seconds.  Induction occurs less rapidly than thiopental [50 – 100% faster than 
midazolam ] but amnesia is more reliable. End points of induction are unresponsiveness to 
command and loss of eyelash reflex.
Patients > 55 yrs and ASA more than or equal to III requires a 20% or more reduction in 
induction  doses.  Midazolam is  used   with  other  anaesthetic  drugs  [opioids  /  barbiturate  / 
propofol  ]  as  coinduction  in  a  dose  of  less  than  0.1  mg/kg.  Emergence  occurs  in  about 
15-17minutes. 
4. Maintenance of anaesthesia :
Midazolam is used to supplement opioids, propofol or other inhalational agents. Though 
there is  lack of analgesia it provides hypnosis  and amnesia. Midazolam 0.6mg/kg lower the 
MAC of halothane by 30%.
Maintenance infusion of midazolam is between 0.25 – 1 mcg / kg / min.
Shorter  context  sensitive  half  time and greater  clearance provides  the  advantage for 
midazolam in maintenance.
ADVERSE EFFECTS
Relatively high margin of safety compared with barbiturates.
Respiratory depression can occur when the drug is given for conscious sedation.
Loss  of  balance and loss  of  head control   in  children  has  been  observed following 
premedication   with midazolam.  Some may also show dysphoric  reactions  like  crying and 
disorientation following intranasal midazolam.
KETAMINE
HISTORY
Victor Maddox of Detroit synthesized phencyclidine and it was introduced into clinical 
use by Greifenstein  and Johnstone in 1958.
Ketamine was synthesized in 1962 by Stevens and was first used in humans in 1965 by 
Corssen and Domino.
PHYSICOCHEMICAL CHARACTERISTICS
Ketamine  is  2-0-chlorophenyl  2-methyl  amino  cyclohexanone  hydrochloride.  The 
molecular weight of 238 kd.21 It is partially water soluble and forms a white crystalline salt 
with a  pKa  of 7.5.  It is prepared in a slightly  acidic pH of 3.5-5.5 and is available in 1%, 5% 
and 10% solutions containing the preservative benza thonium chloride. Ketamine occurs as two 
resolvable optical isomers or enantiomers, the commercial preparation being a racemic mixture 
of both isomers S (+) and R (-) in equal amounts.
 [S (+) isomer produces more intense analgesia, more rapid metabolism and recovery, 
less emergence reaction.]21     
MECHANISM OF ACTION
Ketamine interacts with the following receptors.
A) N-methyl  D- Aspartate  receptor antagonism :
Non competitive antagonist of the NMDA – receptor calcium pore. It also binds to the 
phencyclidine binding receptor site causing inhibition of the NMDA receptor activity ( S(+) 
isomer more affinity) 
B) Opioid receptors :
Ketamine may be an antagonist at mu receptors and an agonist at kappa receptors.
C) Mono aminergic receptors :
Antinociceptive  actions  may  involve  descending  inhibitory  monoaminergic  pain 
pathways.
D) Muscarinic receptors :
Ketamine produces an antagonistic effect at these receptors. Anticholinergic symptoms 
are common.
E) Voltage sensitive calcium channels
PHARMACOKINETICS 
The extreme lipid solubility of ketamine ensures its rapid transfer across the Blood - 
brain barrier (5-10 times that of thiopental). Peak plasma concentration occurs with in 1 minute 
after IV administration and 5 minutes after IM injection. Not significantly bound to plasma 
proteins.
Distribution half  life –  11 to 16 mintues.
Elimination half life –   2 to 3 hours.
Large volume of distribution –   3 L / kg.
Total body clearance – 1.4 L / min.
Alterations in hepatic blood flow  influences  ketamine  clearance  rate .Eg. Halothane .
METABOLISM
By the  hepatic  microsomal  enzymes  cytochrome  P  –  450  .  Major  pathway  is   N- 
demethylation to form nor – ketamine (20-30% activity) which is then hydroxylated to form 
hydroxy norketamine. These products are conjugated to water soluble glucuronide derivatives 
and are excreted in the urine.
Chronic  administration  of  ketamine  can  stimulate  the  enzymes  responsible  for  its 
metabolism ( enzyme induction ) and explain the observation of  tolerance and dependance.
PHARMACOLOGY
Effect on the Central nervous system :
a) Dissociative anaesthesia :
A cataleptic state, with profound analgesia, the eyes remain open with a slow nystagmic 
gaze.  Noncommunicative,  though  wakefulness  appears  to  be  present.  Corneal,  cough  and 
swallowing  reflexes  are  present  but  not  protective.  Varying  degrees  of  hypertonus  and 
purposeless movements can occur. The patient is amnesic.
In  the  thalamo  neocortical  projection  systems,  ketamine  produces  a  functional 
disorganization of pathways and dissociation between the thalamo cortical and limbic system.
Plasma levels for anaesthesia are 0.6 to 2 mcg / ml in adults and 0.8 to 4 mcg / ml in 
children . Duration of action is 10 to 15 minutes and full orientation occurs in 15 to 30 minutes.
b) Ketamine produces an increase in the cerebral blood flow and cerebral metabolic oxygen 
requirement. With increase in cerebral blood flow and generalized increase in the sympathetic 
nervous system response, there is an increase in the intra cranial pressure.
Cerebro vascular response to carbon-di-oxide appears to be preserved with ketamine. 
Prior administration of  thiopental, diazepam or midazolam can blunt the ketamine induced 
increase in cerebral blood flow and cerebral metabolic oxygen requirement.
c) Due to its excitatory central nervous system effects, the drug produces theta – wave activity 
as  well  as  petitmal  seizure  like  activity  in   hippocampus.  Theta  activity  signals  analgesic 
activity. Onset of delta activity coincides with the loss of consciousness. Ketamine does not 
alter the seizure  threshold in epileptic patients but it can produce a myoclonic and seizure like 
activity without cortical epileptic activity.
d) Emergence reaction :
Vivid  dreaming,  extracorporeal  experiences  (sense  of  floating)  and  illusions,  may 
progress to delirium associated with excitement, confusion, euphoria and fear. This occurs in 
the first hour of emergence and usually abates within 1 to several hours.
Emergence delirium occurs secondary to ketamine induced depression of the inferior colliculus 
and medial geniculate nucleus leading to misinterpretation of auditory and visual stimuli. The loss of 
skin and musculo skeletal sensation results in decreased ability to perceive gravity producing a 
sensation of bodily detachment ( floating in space).
Incidence 10 to 30 % . Factors that affect are і) age > 15 years ii) female gender iii) 
doses  > 2 mg/kg IV iv)  personality  problems and psychologic  susceptibility  v)  concurrent 
drugs – with inhaled anaesthetics.
Prevention – benzodiazepines especially midazolam is more effective; can be given 5 
minutes  before  induction.Inclusion  of  thiopental  or  inhalation  can  decrease  the  incidence. 
Premedication with atropine or droperidol may increase the incidence of emergence delirium.
Effect on the Respiratory system :
Ventilatory  response  to  carbon-di-oxide  is  maintained;  transient  decrease  in  minute 
ventilation ( 1-3 min) can occur after a bolus dose ; apnoea can occur after rapid IV or along 
with an opioid.
Respiratory  depression can occur  with the  use  of  sedative  and anaesthetic  drugs.  In 
children, it can cause respiratory depression.
Bronchodilator  activity  is  used  to  treat  bronchospasm  and  status  asthmaticus. 
Mechanisms  include  increased  circulatory  catecholamine  concentrations,  inhibition  of 
catecholamine uptake , voltage sensitive calcium channel block and inhibition of post synaptic 
nicotinic or muscarinic receptors.
Effect on the Cardio vascular system :
Sympathetic  and  pulmonary  arterial  blood  pressure,  heart  rate,  cardiac  output  and 
myocardial oxygen requirements are increased after IV ketamine.
Ketamine  has  a  direct  myocardial  depressant   effect  (negative  ionotropic)  getting 
unmasked  when  the  compensatory  sympathetic  nervous  system  activity  is  exhausted  or 
following depletion of endogenous catecholamine stores.
Enhances the dysrhythmogenicity of epinephrine.
Mechanisms causing stimulation of sympathetic nervous system include: direct central 
nervous system stimulation and increased outflow, depression of baroreceptor reflex via N-
methyl  D-aspartate  receptor,  inhibition  of  norepinephrine  uptake  into  post  ganglionic 
sympathetic nerve endings and associated increase of plasma catecholamines.
Methods used to block ketamine induced sympathetic stimulation are use of alpha and 
beta  adrenergic  antagonist,  vasodilators,  clonidine,  prior  administration  of 
benzodiazepines,inhalational anaesthetics, barbiturates, and droperidol.  
DRUG INTERACTIONS
1. Ketamine in the presence of halothane causes hypotension, unmasking of the direct 
depressant effect by inhalation anaesthetics.
2. Ketamine causes a dose dependent decrease in minimum alveolar concentration of 
volatile anaesthetics. 
3. Volatile anaesthetics prolong the duration of  ketamine.
4. Ketamine enhances non depolarizing neuro muscular relaxants by interfacing with 
calcium ion  binding . 
5. With succinyl choline, ketamine can prolong the duration of action by inhibition of 
plasma cholinesterase  
6. Pancuronium enhances the cardiac – stimulating effects.
7. Seizures  have  been  reported  in  asthmatics  receiving  aminophyline  following 
administration of ketamine:
8. Preservative  chlorobutanol  is neurotoxic  and this precludes its use in subarachnoid 
or epidural  space. 
9. Ketamine with propofol  is strictly additive  and not synergistic, thus the dose of 
each should be reduced by about half .
10.  Barbiturate & narcotics prolong the recovery time.  
USES 
I. INDUCTION AND MAINTENANCE : 
IM induction in children and  mentally  retarded patients, for burn dressing  changes , 
wound debridements and  skin grafting  procedures.24 
Induction agent of choice  in patients with reactive airway disease or bronchospasm or 
asthma. Its use as cardiac stimulant is advantageous in trauma victims with acute hypovolemia 
provided there is sufficient  sympathetic reserve. Patients  with septic shock  also benefit from 
ketamine. 
Ketamine  anaesthesia  is  used  for  cardiac  tamponade,  constrictive  Pericarditis  & 
congenital  heart disease with right to left shunt.  
  In patients with malignant hyperthermia and anterior  mediastinal mass , ketamine use 
maintains spontaneous  ventilation  (inhalation contraindicated). 
Diazepam 0.5mg /kg IV and ketamine 0.5 mg /kg IV followed by a continuous infusion 
of ketamine 15 to 30  µg/kg /mint can be used in patients with coronary artery disease. Low 
dose  ketamine can be used as an analgesic following  thoracic surgery. 
Induction : 0.5 – 2 mg /kg  IV 
4 - 6 mg/ kg   IM
Maintenance :       
0.5 – 1 mg /kg IV 
30 – 90 µg/kg /min IV
II. SEDATION :
Ketamine  sedation  is  used  for  paediatric  procedures  like  cardiac  catheterization, 
radiation therapy24, dressing changes and dental work. 
0.2 - 0.8 mg/kg IV 
2 - 4 mg/kg IM 
Ketamine 0.5mg/kg IV combined with diazepam 0.15mg/kg IV is better accepted for 
supplementation of regional anaesthesia.
III. NEURAXIAL ANALGESIA :
Extra  dural  (30mg) and intrathecal  (5mg) administration produces  variable  and brief 
analgesia.
ADVERSE EFFECTS
Increased Blood Pressure, tachycardia, tonic & clonic muscle movements, tremors  and 
vocalization,  emergence reaction, visual hallucination, vivid dreams or illusions.
 Less  frequently  bradycardia,  hypotension,  respiratory  depression,  apnoea,  vomiting, 
cardiac arrhythmias, laryngo spasms and airway obstructions occur. 
Rarely double vision, loss of appetite, nystagmus, skin rash (red skin) etc are noted.
CONTRAINDICATION
1. Severe Cardio vascular diseases.
2. Severe hypertension.
3. Recent myocardial infarction 
4. Stroke
5. Cerebral trauma
6. Intra cerebral mass / Hemorrhage.
7. Congestive cardiac failure.
8. Tachyarrhythmias 
9. Thyrotoxic state.
10. Increased intra ocular pressure and CSF pressure 
11. Sensitivity to ketamine.
12. Alcohol / Drug abuse.
PREGNANCY
Crosses placenta, reported to cause birth defects in animals, secretion in breast  milk is not 
known.
PAEDIATRICS
In neonates and  < 4 months increased risk of respiratory complications.
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anesthesia without causing significant side effects. Forty five children (ASA 1 and 2, aged 1-7 years) 
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separation from parents. This double blind, placebo-controlled study concluded that oral midazolam 
0.5mg/kg is a safe and effective premedicant and that 0.75 and 1mg/kg while offering no additional 
benefit, caused more side effects.
 4. Pan  AK,  Rudra  A,  Ghosh  M,  Biswas  BN,  Sen  A,  Kar  A.
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Sixty children of ASA grade I and II, aged between 3 and 8 years were randomly enrolled in a 
observer – blinded fashion into 3 different groups in equal numbers. They found that midazolam 
0.5mg/ kg or combination of  midazolam 0.25 mg/kg plus ketamine 2.5mg/kg provided a better 
premedication in children than ketamine 5mg/kg when given orally 30 minutes before the induction of 
anaesthesia.
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W Funk, W Jakob, T Riedl and K Taeger; 
In a prospective, randomized double blind study it was observed that ketamine 3 mg/kg 
combined with midazolam 0.5mg/kg had significantly better anxiolysis and separation from parents 
than midazolam or ketamine alone. The duration of action and side effects of the combination were 
similar to those of midazolam alone.
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II scheduled for out patient surgery were assigned to three groups (n=20) receiving midazolam 
0.5mg/kg or ketamine 5mg/kg or a placebo ie) apple juice, 30 minutes before separation from parents. 
There was statistically no significant difference between the ketamine and the midazolam groups in the 
time of onset of sedation, maximum sedation achieved, amnesia, induction time and recovery time. 
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Morse Z, Sano K, Kanri T.
Ten ASA physical status I volunteers were administered loading doses of 0.07 mg/kg of 
midazolam followed by 0.7mg/kg of ketamine. The same amount of midazolam and ketamine was then 
infused constantly over 1 hour. The combined non narcotic, sedoanalgesic technique maintained 
spontaneous ventilation,  stable cardio respiratory parameters and hence was suggested as an alternative 
to traditional conscious sedation or general anesthesia.
9. Anaesthesia and Intensive Care 2004;32:246-9.
Darlong V, Shende D, Subramanyam MS, Sunders R, NaikA.
The study showed that a combination of ketamine 3 mg/kg plus midazolam 0.25 mg/kg orally 
had a faster onset, better efficiency and more rapid recovery than the administration of oral ketamine 
6mg/kg or oral midazolam 0.5 mg/kg alone.
METHODOLOGY
A clinical randomized, blind-prospective study was performed to assess the quality of 
premedication in children,  following the administration of either  of  the two doses of oral 
ketamine with midazolam or midazolam alone or ketamine alone. 
The clinical study was carried out in 100 patients, who got admitted in the paediatric 
surgery department of Government Rajaji Hospital, Madurai for elective surgeries during the 
period  December  2004  to  February  2006.  This  study  was  conducted  after  obtaining  the 
approval from the hospital ethical committee and with the informed consent of the parents. 
INCLUSION CRITERIA 
• The age group of children selected for this study was between 1 and 12 years (both 
inclusive). 
• Only patients belonging to American Society of Anesthesiologists (ASA) physical status 
I were chosen for the study. This was done to avoid the influence of associated diseases 
on the observation. 
• Duration of the surgical procedures were not less than 30 minutes. 
• Informed consent, from the parents was obtained.    
• All the children were kept under overnight starvation prior to surgery.
EXCLUSION CRITERIA 
• Patients  on  other  sedative  drugs,  neuroleptic  drugs,  anticonvulsants  and  barbiturates 
were excluded from the study for fear of their possible influence on the effects of the 
premedicant drug.
• Children, spitting out the drug following the administration of premedicants along with 
sugar crystals, were excluded from the study to avoid bias in results. 
• Children, suffering from upper or lower respiratory infections were excluded.  
PREANAESTHETIC EVALUATION 
All the patients included in the study underwent a preanaesthetic assessment prior to the 
surgery, with due importance given to the following:
a. History –  a  detailed review of  the  past  and present  clinical  conditions  with history 
regarding previous surgeries and medications etc., 
b. Clinical examination –  a thorough examination of the cardiovascular and respiratory 
systems. 
c. Investigation  –  Hb%,  blood  urea,  blood  sugar,  serum  Creatinine,  urine  analysis, 
bleeding time and clotting time. 
METHOD 
The children were randomly allocated into four groups of twenty five each as per the 
premedications given. 
Group A – ketamine 1 mg / kg combined with midazolam 0.3 mg / kg. 
Group B – ketamine 2 mg / kg combined with midazolam 0.3 mg / kg. 
Group C – ketamine 6 mg / kg alone. 
Group D – midazolam 0.5 mg / kg alone. 
In Group – A 
 Parenteral  formulation  of  ketamine  (50  mg  per  ml  vial)  in  a  dose  of  1mg/kg  was 
combined with parenteral formulation of midazolam (5 mg per ml ampoule) in a dose of 0.3 
mg/kg.  
This combination was then mixed with equal volume of sugar crystals using a stirrer. 
The prepared solution was given to the children to drink either from a tumbler or a palladai. 
Immediately after swallowing the drug,  the child was offered 2-3 gms of sugar crystals  to 
chew, inorder to avoid the bitter taste of the drug. This was given 30 minutes prior to the 
induction. 
In Group – B
 Parenteral formulation of ketamine (from 50 mg per ml vial) in a dose of 2 mg/kg was 
combined with parenteral formulation of midazolam (from 5 mg per ml ampoule) in a dose of 
0.3 mg/kg. To the prepared mixture was added equal volumes of sugar crystals and dissolved 
using a stirrer. The prepared solution was then given to the children to drink from a tumbler or 
paladai.        2-3gms of sugar crystals were given to chew to avoid the bitter taste of the 
premedicant. This was done 30 minutes prior to induction. 
In Group – C 
 Parenteral formulation of ketamine (from 50 mg per ml, vial) in a dose of 6 mg/kg, was 
taken alone and sugar crystals were dissolved in it. This was given to children to drink as a 
syrup. After swallowing the drug, the children were given 2-3 gms of sugar crystals to chew to 
avoid any bitter  taste  of  drug.  The premedication  was administered 30 minutes  before  the 
induction. 
In Group – D 
  Parenteral form of midazolam (5 mg per ml, ampoule) in the dose of 0.5mg/kg, was 
mixed with sugar crystals till it dissolved and was given orally 30 minutes prior to induction of 
anaesthesia. Following the drug 2-3 gms of sugar crystals were given to chew, to avoid the 
bitter taste of the drug. 
CLINICAL STUDY 
Thereafter the child was observed for any changes in mood, behaviour, sleepiness and 
appearance of any side effects like vomitting, increased salivation, hiccough, nystagmus etc., 
SEDATION 
 At 30 minutes following the oral premedication, the level of sedation was graded by 
evaluating the child’s appearance with the help of a five point sedation score as below: 
Score Sedation level
1 Barely arousable [full sleep]
2 Eyes closed, light sleep
3 Eyes open but looks drowsy
4 Awake
5 Agitated
A sedation score of 3 or less, was considered as GOOD and scores of 4 & 5 as POOR.  
ANXIETY 
The emotional state of the child or the level of anxiety at the time of separation from the 
parents, was assessed using a four point anxiety score. 
Inside the operating room, the level of anxiety at the time of intravenous cannulation and 
also the anxiety level on application of mask for preoxygenation were evaluated using the same 
four point anxiety score as below: 
 Score Anxiety level 
1 Calm, sleepy
2 Little apprehensive but withdrawn from surroundings 
3 Crying 
4 Agitated and difficult to control 
ANAESTHETIC SEQUENCE 
Intravenous cannulation was performed in all the children and injection atropine 0.02 
mg/kg  was  given  intravenously.  All  the  children  were  preoxygenated,  through  face  mask. 
Induction was done with 2.5% solution of injection thiopentone sodium 5 mg/kg followed by 
injection  succinylcholine  2  mg/kg  to  facilitate  tracheal  intubation  with  an  appropriate  size 
uncuffed endotracheal tube. Anaesthesia was maintained with nitrous oxide – oxygen, injection 
pentazocine 0.6 mg/kg as opioid and injection atracurium 0.3 mg/kg as the non depolarizer. At 
the end of surgery the neuromuscular blockade was reversed with injection neostigmine 0.04 
mg/kg  and  injection  atropine  0.02  mg/kg  in  titrated  doses.  Any  side  effects  or  undue 
complications in the perioperative period were noted. 
ANALYSIS
The observations were analysed and the data was compared between the groups by using 
students ‘t’ – test. A value of p < 0.05 was taken as a statistically significant difference. For 
continuous variables [age, weight] the analysis was performed as mean ± standard deviations. 
OBSERVATIONS AND RESULTS




Age (yrs) Weight (kg) Sex (M/F)
Group – A 4.92 ± 2.84 13.88 ± 4.37 19 / 6
Group – B 4.82 ± 2.54 13.48 ± 3.93 21 / 4
Group – C 6.93 ± 2.93 16.8 ± 4.67 22 / 3
Group – D 3.96 ± 2.66 12.56 ± 4.04 22 / 3
All the values are mean ± standard deviation except sex criteria. 
All the four groups were comparable in age, sex and weight. 








Ketamine 2 mg/kg plus 
Midazolam 0.3 mg/kg
4.96
Group – C Ketamine 6 mg/kg 5.5
Group – D Midazolam 0.5 mg/kg 3.8
The average weight distribution among each group was considered to calculate the dose 
and the drug so obtained was used to measure the pH. The pH was measured using the Merck 
pH indicator paper and was confirmed by the digital pH meter. 
The pH of all these drugs were more than the most conservative pH limit of 2.5, thought 
to promote lung damage after aspiration of gastric contents. 












1 Barely arousable, full sleep 2 0 1 2
2 Eyes closed, light sleep 4 9 5 4
3 Eyes open but looks drowsy 16 13 11 12
4 Awake 3 3 8 7
5 Agitated 0 0 0 0
When comparing Group A and Group B, the average sedation score for Group A was 
2.8 ± 0.7483, and Group B was 2.76 ± 0.6499. When applying student ‘t’ distribution, the ‘t’-
value was 0.1977 and p value = 0.8441. The p value  was  >0.05 which is not significant. 
Comparing the average score,  Group B appears to have a better score than Group A ( the 
average score was less 2.76 vs 2.8) but the difference in the level of sedation achieved between 
the two groups was not statistically significant. 
When comparing Group A and Group C, the average sedation score was 2.8 ± 0.7483 
and 3.04 ± 0.8237 respectively. The ‘t’ value was 1.0565 and p value = 0.2960, p >0.05 the 
difference was not significant. Though Group A has better average score than Group C the 
difference in the achieved sedation was not statistically significant. 
On comparing Group A and Group D, the average score was 2.8 ± 0.7483 and 2.96 ± 
0.8709 respectively. The ‘t’ value 0.6827 and p = 0.4981, p>0.05 not significant. Though the 
average sedation score  achieved by Group A was better  than Group D (2.8 vs  2.96)  their 
difference was not statistically significant. 
Comparing Group B and Group C. the average score was 2.76 ± 0.6499 and 3.04 ± 
0.8237 respectively. The ‘t’ value 1.3074 and p = 0.1973, p >0.05 not significant. Thus the 
average score was better for Group B than Group C but the difference was not statistically 
significant. 
Comparing the Groups B and D the average score was 2.76 ± 0.6499 and 2.96 ± 0.8709 
respectively. But the t value of 0.9017 with a p = 0.3717, (more than 0.05) was not significant. 
Group B with a better average score than Group D has not produced a statistically significant 
difference in the level of sedation. 
Comparison of Group C and Group D showed an average score of 3.04 ± 0.8237 and 
2.96 ± 0.8709 respectively. The ‘t’ value was 0.3269 and the p of 0.7451 (more than 0.05) 
statistically insignificant. Hence Group D has a better average sedation score than Group C but 
the difference in level was not statistically significant.   
Overall analysis of the level of sedation showed that all 4 Groups (A, B, C, D) provided 




No. of children (percentage) 
Good score 
Score 3 or less
Poor score 
Score 4 & 5 
Group – A 22 (88%) 3(12%)
Group – B 22 (88%) 3 (12%)
Group – C 17 (68%) 8 (32%)
Group – D 18 (72%) 7 (28%)












1 Calm, sleepy 8 14 6 3
2
Little apprehensive, withdrawn 
from surroundings 
15 10 18 16
3 Crying 2 1 1 6
4 Agitated and difficult to control 0 0 0 0
When comparing Group A with Group B by applying student ‘t’ test, the average score 
was Group A 1.76 ± 0.5851 and Group B 1.48 ± 0.5741, t value was 1.6734 and p value = 
0.1008,  more than 0.05. The performance of both groups were similar with no statistically 
significant difference. 
Comparing Group A and Group C the average scores were 1.76 ± 0.5851 and 1.8 ± 
0.4899 respectively.  ‘t’  value  was 0.2568 and  p value  = 0.7984,  more  than 0.05 and not 
significant. Hence, there was no statistically significant difference in the performance between 
Groups A and C during parental separation.    
When comparing Group A and Group D the average score were 1.76 ± 0.5851 and 2.12 
± 0.5879 respectively. ‘t’ value was 2.1263 and p value = 0.0386, which was less than 0.05 and 
statistically significant. Group A provides a better parental separation than Group D since the 
average score was less (1.76 vs 2.12) and the observed difference was statistically significant. 
Comparison of Group B and Group C showed the average scores 1.48 ± 0.5741 and 1.8 
± 0.4899 respectively ‘t’ value 2.0772 and p value = 0.0432 which was less than 0.05 and 
hence statistically significant.  So, Group B provided a better control of anxiety on parental 
separation than Group C (1.48 vs 1.8). 
When Group B was compared with Group D, the average score was 1.48 ± 0.5741 and 
2.12 ± 0.5879, respectively, t-test value was 3.8156 with a p of 0.0004, p < 0.05 which was 
statistically significant. Group B scores over Group D in alleviating the anxiety of parental 
separation (1.48 vs 2.12).  
Finally comparing Groups C & D the average scores were 1.8 ± 0.4899 and 2.12 ± 
0.5879 respectively. The ‘t’ value was 2.0485 with a p = 0.0460 which is less than 0.05 and 
statistically significant. So, Group C has a better score and statistically significant difference 
than Group D (1.8 vs 2.12). 
Further analysing the children who were either calm or crying at separation from their 




No. of children (percentage) 
Calm 
Score 1 and 2
Crying 
Score 3 & 4 
Group – A 23 (92%) 2 (8%)
Group – B 24 (96%) 1 (4%)
Group – C 24 (96%) 1 (4%)
Group – D 19 (76%) 6 (24%)












1 Calm, sleepy 6 12 4 1
2
Little apprehensive, withdrawn from 
surroundings 
14 12 13 11
3 Crying 5 1 8 13
4 Agitated and difficult to control 0 0 0 0
When comparing Group A and Group B, the average score was 1.96 ± 0.6621 and 1.56 
± 0.5713 respectively. The ‘t’ value was 2.2408 and a p of 0.0297, p < 0.05 was statistically 
significant.  Group  B  has  a  better  average  score  (1.56  vs  1.96)  than  Group  A  and  thus 
suppresses the anxiety level at intravenous cannulation in a statistically significant way than 
Group A. 
Comparing Groups A and C, the average score was 1.96 ± 0.6621 and 2.16 ± 0.6741 
respectively. The ‘t’ value 1.0370 and p value 0.3050, p > 0.05 was statistically not significant, 
so the level of anxiety on intravenous cannulation were comparable between the Groups A and 
C. 
On comparing Group A and Group D the average scores were 1.96 ± 0.6621 and 2.48 ± 
0.5741 respectively. The ‘t’ value 2.9070 with a p 0.0055, p < 0.05 was statistically significant. 
Group A has a better score than Group D since the average score was les (1.96). 
Comparing Group B and Group C showed an average score of 1.56 ± 0.5713 and 2.16 ± 
0.6741 respectively. The ‘t’ value was 3.3265 with a p of 0.0017, p < 0.05 was significant 
statistically. Group B was better than Group C (1.56 vs 2.16) in keeping the child calm during 
intravenous cannulation.   
Comparison of Group B and Group D revealed an average score of 1.56 ± 0.5713 and 
2.48 ± 0.5741 respectively. They had a ‘t’ value 5.5648 and p value 0.00001, p < 0.05 made the 
comparison statistically significant. Hence the anxiety level was significantly better in Group B 
than Group D (1.56 vs 2.48). 
Comparing Group C and Group D average score were 2.16 ± 0.6741 and 2.48 ± 0.5741 
respectively,  with  a  ‘t’  value  1.7705  and  p  value  0.0830  p  >  0.05  was  statistically  not 
significant. There was no significant difference in anxiety level between the Groups C and D. 




No. of children (percentage) 
Calm 
Score 1 and 2
Crying 
Score 3 & 4 
Group – A 20 (80%) 5 (20%)
Group – B 24 (96%) 1 (4%)
Group – C 17 (68%) 8 (32%)
Group – D 12 (48%) 13 (52%)
   












1 Calm, sleepy 5 12 4 2
2
Little apprehensive, withdrawn 
from surroundings 
15 12 15 9
3 Crying 5 1 6 14
4 Agitated and difficult to control 0 0 0 0
Comparing Group A and Group B it was seen to have an average score of 2 ± 0.6325 
and 1.56 ± 0.5713 respectively with a ‘t’ value 2.5291 and a p = 0.0148, i.e., p < 0.05 making it 
statistically  significant.  Thus  Group B has  a  better  score  and statistically  significant  mask 
acceptance than                     Group A(1.56vs 2).
When Group A and Group C were compared average score was 2 ± 0.6325 and 2.08 ± 
0.6274 respectively. They had a ‘t’ value 0.4399 and p of 0.6620, p > 0.05 not significant. 
Though Group A had a better average score than Group C (2 vs 2.08) both the groups had a 
comparable mask acceptance without significant difference. 
Comparing Group A and Group D their average scores were 2 ± 0.6325 and 2.48 ± 0.64 
respectively. ‘t’ value 2.6133 and p value = 0.0119, i.e., p < 0.05 statistically significant. Hence 
Group A showed statistically significant difference in accepting mask for induction better than 
Group D (2 vs 2.48). 
Comparisons of Group B and Group C showed average scores as 1.56 ± 0.5713 and 2.08 
± 0.6274 respectively, ‘t’ value was 3.0022 and p value = 0.0042, p < 0.05 was statistically 
significant.  Thus  Group  B  fared  better  than  Group  C  (1.56  vs  2.08)  showing  significant 
difference in mask acceptance. 
When Groups B and D were compared their average were 1.56 ± 0.5713 and 2.48 ± 0.64 
respectively.  Their  ‘t’  value  was  5.2536  and  p  value  0.00001,   P  <  0.05  and  statistically 
significant.  So, Group B reduces the anxiety level  quite significantly than Group D during 
mask application. 
Finally comparing Group C and Group D showed average scores as 2.08 ± 0.6274 and 
2.48 ± 0.64 respectively. Their ‘t’ value was 2.1865 and p value = 0.0337 which was less than 
0.05 hence statistically significant.  So, Group C had better score than Group D with a low 
average score (2.08 vs 2.48).
Analysing  children  who  remained  calm or  cried  on  applying  mask  for  oxygenation 




No. of children (percentage) 
Calm 
Scores 1 and 2
Crying 
Scores 3 & 4 
Group – A 20 (80%) 5 (20%)
Group – B 24 (96%) 1 (4%)
Group – C 19 (76%) 6 (24%)
Group – D 11 (44%) 14 (56%)
VII. ADVERSE EVENTS 
In Group C, with ketamine alone, 8% children had nausea and vomiting, 16% showed 
increased salivations and secretions intraoperatively and a further 16% children were drowsy in 
the post operative period. 
In  Group D,  with midazolam alone,  8% children had hiccoughs and another  8% of 
children showed a delayed recovery with post operative drowsiness. 
In Group A and Group B  no significant side effects were reported.
DISCUSSION
Fears  of  injection,  operations,  physicians  and peculiar  operation theatre environment 
where the children are separated from their parents prior to anaesthesia invariably produces 
traumatic experiences in the tender mind of the young children. An atraumatic premedication 
can minimise these problems when a calm separation from parents and a smooth induction of 
anaesthesia is achieved. 
It has been a common practice to use oral midazolam and oral ketamine for anxiolysis 
and sedation in paediatric anaesthesia. Several studies have compared the efficacy of these two 
drugs as oral premedicants. In this study we have combined oral ketamine and midazolam in 
two different doses and have evaluated their synergistic action and compared their level of 
sedation and anxiolysis when either of the drugs were given alone. 
STUDY DESIGN 
   McMillan et  al  and Lerman et  al15 using the  parenteral  preparation orally  compared 
different doses of midazolam (0.5mg, 0.75mg, 1mg per kg) and concluded that oral midazolam 
in a dose of 0.5 mg/kg is safe and effective. We have used parenteral preparation of midazolam 
orally in the dose of 0.5mg/kg in this study (Group D). 
Gutstein and Gregory George et al8 after comparing different doses of ketamine and 
found that oral 6 mg/kg ketamine provides predictable and satisfactory premedication without 
significant side effects.  Mehrotra et al reported similar results with 6 mg/kg oral ketamine. 
Hence in this study it was decided to use ketamine in the dose of 6 mg/kg orally (Group C). 
Astuto et al2 have used midazolam 0.3mg/kg with ketamine 1mg/kg or ketamine 2mg/kg 
in  his  study.  Funk  et  al6 used  ketamine  3mg/kg  with  midazolam  0.5mg/kg  orally  in 
combination. Hence with the idea of lowering the doses and providing an effective combination 
we arrived at the different dose combinations as ketamine 1 mg/kg with midazolam 0.3 mg/kg 
(Group A) and ketamine 2 mg/kg with midazolam 0.3 mg/kg (Group B).      
Mishra and Gairola et al16, have found that administering parenteral formulations as oral 
premedicants  in  paediatric  age groups is  more  acceptable,  effective and safe.  Many of  the 
previous studies have used sugar crystals22 or apple juice4, or strawberry syrup6 or chocolate 
flavours8 etc  to  mask the  bitter  taste  of  parenteral  formulations.  Considering  all  the  above 
studies, we have used the parenteral formulations orally with sugar crystals added to it in this 
study. All the children accepted the preparations very well, except for one child who was given 
midazolam orally with sugar, spitted out the drug partially, this child was excluded from the 
study. 
We did not administer oral atropine along with the test drug because it also imparts bitter 
taste and delays gastric emptying. So we decided to give atropine 0.02 mg/kg intravenously just 
prior to induction, which was also useful in preventing the pooling of secretions induced by 
ketamine during intubations.      
The pH of the drugs used in this study remained above 2.5. According to Teabeut et al23, 
the conservative pH limit thought to prevent lung damage after aspiration of gastric contents 
was more than pH 2.5. Further the premedicant volume used was kept at less than 0.4 ml/kg 
(John,  Lockhart  et  al11),  the  minimal  gastric  volume  to  avoid  aspiration  pneumonitis 
(Anaesthesiology clinics of North American, Dec 1996)9. 
RESULT ANALYSIS 
 Suranjit Debnath and Yash Pand et al22 have compared the parenteral formulations of 
ketamine  6  mg/kg  and  midazolam 0.5  mg/kg  given  orally  mixed  with  sugar  crystals  and 
concluded  that  ketamine  at  6  mg/kg  orally  provides  better  sedation  and  anxiolysis  than 
midazolam. Anxiolysis for mask application was not studied. 
Astuto et al2 showed that midazolam 0.3 mg/kg with ketamine 2 mg/kg provides better 
sedation and anxiolysis than midazolam 0.5 mg/kg alone. No data on IV canulation is available. 
Funk et al6 have found that ketamine 3 mg/kg with midazolam 0.5 mg/kg provided significantly 
better anxiolysis than with midazolam or ketamine alone. Acceptance of face mask had not 
been considered. 
From the results of this study we see that all the four groups provide an equally effective 
(P>0.05)  good  level  of  sedation,  98%  of  children  receiving  the  combined  ketamine  and 
midazolam premedications  (both Group B and Group A) show a good acceptable sedation 
score. Comparatively it  was only 72% among midazolam alone group (D) and 68% among 
ketamine alone group (C).  We infer that,  ketamine 1mg/kg with midazolam 0.3 mg/kg and 
ketamine            2 mg/kg with midazolam 0.3 mg/kg when given orally as premedicants 
provides a good and acceptable sedation similar to midazolam 0.5 mg/kg and ketamine     6 mg/
kg orally.     
From the study of the anxiety level  during separation from parents,  we see that  the 
children  receiving  ketamine  2  mg/kg  with  midazolam 0.3  mg/kg  show better  results  with 
statistically significant difference (p<0.05) than those receiving midazolam 0.5 mg/kg alone 
and ketamine 6 mg/kg alone. The difference between ketamine 2 mg/kg with midazolam 0.3 
mg/kg  (96%)  calm)  and  ketamine  1  mg/kg  with  midazolam  0.3  mg/kg  (92%  calm)  is 
insignificant (p>0.05). Ketamine 1 mg /kg with midazolam 0.3 mg/kg show better separation 
than midazolam 0.5 mg/kg alone (p<0.05) but  the results  are comparable with ketamine 6 
mg/kg alone ( p > 0.05).
With intravenous canulation, the dose of ketamine 2 mg/kg with midazolam 0.3 mg/kg 
achieve significant reduction in anxiety (96% calm) than all the other three groups (p<0.05). 
Ketamine 1 mg/kg with midazolam 0.3 mg/kg (80% calm) shows similar results (p>0.05) as 
ketamine 6 mg/kg         (68% calm) but better than (p<0.05) midazolam 0.5 mg/kg (48%calm) 
during cannulation. 
For acceptance of mask, ketamine 2 mg/kg with midazolam 0.3 mg/kg emerge more 
successful (96% calm) producing a significantly better anxiolysis (p<0.05) than all the other 
three  groups.  Anxiolysis  of  ketamine1  mg/kg  with  midazolam  0.3  mg/kg  (80%  calm)  is 
comparable (p>0.05) with that of ketamine 6 mg/kg alone (76% calm) but both the groups are 
better than (p<0.05) midazolam 0.5 mg/kg (44% calm).
SUMMARY
A low dose combination of both ketamine and midazolam [both ketamine 1mg/kg with 
midazolam 0.3 mg/kg and ketamine 2 mg/kg with midazolam 0.3 mg/kg] when given orally as 
premedicants  to  children  produce  good  and  acceptable  sedation  comparable  with  that  of 
ketamine 6 mg/kg alone and midazolam 0.5 mg/kg alone. 
Two mg/kg of  ketamine with 0.3 mg/kg of  midazolam when given orally  improves 
parental separation, achieve more success during intravenous cannulation and also shows better 
acceptance of face mask than ketamine         6 mg/kg alone or midazolam 0.5 mg/kg alone. 
CONCLUSION
Combining both ketamine and midazolam and reducing their individual doses produces good 
sedation and better anxiolysis in children with no side effects. 
 Thus ketamine 2 mg/kg with midazolam 0.3 mg/kg has emerged as a more successful 
oral premedicant to calm a troubled child, ease the separation from parents and to facilitate the 
induction for a smooth conduct of anaesthesia. 
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PROFORMA
Name : Age: Sex: IP No: Wt:
Case : Plan:       
ASA Risk: Group:
Pre – medication Drug: Dose:                  Time:
SEDATION SCORE :
SCORE SEDATION LEVEL OBSERVATION
1. Barely arousable (Full Sleep)
2. Eyes closed (light sleep)












1 Calm or Sleepy









Increased Salivation and Secretions
Hiccoughs
Post Operative drowsiness
Delay in Recovery 
Others

